Literature DB >> 4325123

Two-colour immunofluorescence studies on EBV-determined antigens.

G Klein, L Gergely, G Goldstein.   

Abstract

Mesh：

Substances：

Year:  1971        PMID： 4325123      PMCID： PMC1712959     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  22 in total

1.  Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups.

Authors:  W Henle; G Henle; H C Ho; P Burtin; Y Cachin; P Clifford; A de Schryver; G de-Thé; V Diehl; G Klein
Journal:  J Natl Cancer Inst       Date:  1970-01       Impact factor: 13.506

2.  Antibody patterns in different human sera against intracellular and membrane-antigen complexes associated with Epstein-Barr virus.

Authors:  A Svedmyr; A Demissie; G Klein; P Clifford
Journal:  J Natl Cancer Inst       Date:  1970-03       Impact factor: 13.506

3.  Studies on the relation of membrane immunofluorescence to Epstein-Barr virus infection.

Authors:  V C Dunkel; R F Zeigel
Journal:  J Natl Cancer Inst       Date:  1970-01       Impact factor: 13.506

4.  Membrane immunofluorescence reactions of Burkitt lymphoma cells from biopsy specimens and tissue cultures.

Authors:  G Klein; P Clifford; E Klein; R T Smith; J Minowada; F M Kourilsky; J H Burchenal
Journal:  J Natl Cancer Inst       Date:  1967-11       Impact factor: 13.506

5.  Immunofluorescence in cells derived from Burkitt's lymphoma.

Authors:  G Henle; W Henle
Journal:  J Bacteriol       Date:  1966-03       Impact factor: 3.490

6.  Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis.

Authors:  G Henle; W Henle; V Diehl
Journal:  Proc Natl Acad Sci U S A       Date:  1968-01       Impact factor: 11.205

7.  An approach to the mapping of antigens on the cell surface.

Authors:  E A Boyse; L J Old; E Stockert
Journal:  Proc Natl Acad Sci U S A       Date:  1968-07       Impact factor: 11.205

8.  Relation between Epstein-Barr viral and cell membrane immunofluorescence of Burkitt tumor cells. I. Dependence of cell membrane immunofluorescence on presence of EB virus.

Authors:  G Klein; G Pearson; J S Nadkarni; J J Nadkarni; E Klein; G Henle; W Henle; P Clifford
Journal:  J Exp Med       Date:  1968-11-01       Impact factor: 14.307

9.  Relation between Epstein-Barr viral and cell membrane immunofluorescence in Burkitt tumor cells. IV. Differentiation between antibodies responsible for membrane and viral immunofluorescence.

Authors:  G Pearson; G Klein; G Henle; W Henle; P Clifford
Journal:  J Exp Med       Date:  1969-04-01       Impact factor: 14.307

10.  Relation between Epstein-Barr viral and cell membrane immunofluorescence in Burkitt tumor cells. 3. Comparison of blocking of direct membrane immunofluorescence and anti-EBV reactivities of different sera.

Authors:  G Klein; G Pearson; G Henle; W Henle; G Goldstein; P Clifford
Journal:  J Exp Med       Date:  1969-04-01       Impact factor: 14.307
View more
  10 in total

1.  Amounts of Epstein-Barr virus DNA in somatic cell hybrids between burkitt lymphoma-derived cell lines.

Authors:  M Andersson
Journal:  J Virol       Date:  1975-11       Impact factor: 5.103

2.  Epstein-Barr virus genomes with properties of circular DNA molecules in carrier cells.

Authors:  A Adams; T Lindahl
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

3.  Replication of latent Epstein-Barr virus genomes in Raji cells.

Authors:  A Adams
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

4.  Epstein-Barr virus-binding receptor on the surface of chronic lymphocytic leukaemic lymphocytes.

Authors:  L Gergely; J Czeglédy; L Váczi; P Gergely
Journal:  Experientia       Date:  1974-07-15

5.  Circular Epstein-Barr virus genomes of reduced size in a human lymphoid cell line of infectious mononucleosis origin.

Authors:  A Adams; G Bjursell; C Kaschka-Dierich; T Lindahl
Journal:  J Virol       Date:  1977-05       Impact factor: 5.103

6.  Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx.

Authors:  G Klein; B C Giovanella; T Lindahl; P J Fialkow; S Singh; J S Stehlin
Journal:  Proc Natl Acad Sci U S A       Date:  1974-12       Impact factor: 11.205

7.  Expression of Epstein-Barr virus (EBV) DNA and cloned DNA fragments in human lymphocytes following Sendai virus envelope-mediated gene transfer.

Authors:  D J Volsky; T Gross; F Sinangil; C Kuszynski; R Bartzatt; T Dambaugh; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

8.  Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas.

Authors:  G Klein; T Lindahl; M Jondal; W Leibold; J Menézes; K Nilsson; C Sundström
Journal:  Proc Natl Acad Sci U S A       Date:  1974-08       Impact factor: 11.205

9.  Effects of DNA synthesis inhibitors on early antigen expression following primary infection or superinfection by Epstein-Barr virus.

Authors:  B I Lidin; E W Lamon
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

10.  Surface markers on human B and T lymphocytes. II. Presence of Epstein-Barr virus receptors on B lymphocytes.

Authors:  M Jondal; G Klein
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.